Although Pten is intensively studied in solid tumors and T cell-acute lymphoid leukemia (T-ALL) [29-32], little is known about Pten in CML until we show that Pten inhibits LSCs and CML development [27]. The gene discussed is PTEN; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.